RxDoctor Payments Data

Keith Michael, MD

Orthopaedic Surgery of the Spine · Atlanta, GANPI 1033385679

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (42.0%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Alphatec Spine, Inc at 54.3% of the total.

$194,479in general payments, 2019–2025

Across 349 payments — averaging $557.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alphatec Spine, Inc$106K
  • Medtronic$44K
  • Orthofix Medical, Inc.$24K
  • Stryker$11K
  • Seaspine Orthopedics Corporation$10K
  • Globus Medical$278
  • plus $193 from 2 others
$178,957in research payments, 2019–2025

Across 54 payments — averaging $3314.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$127K
  • Pfizer$24K
  • Seaspine Orthopedics Corporation$20K
  • Orthofix Medical, Inc.$8K

What the payments were for

  • Consulting fees$73,89138%
  • Speaking & faculty fees$27,95314%
  • Travel & lodging$81,59542%
  • Food & beverage$11,0406%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Alphatec Spine, Inc144$105,580
Medtronic(2 entities)75$43,638
Orthofix Medical, Inc.85$24,354
Stryker2$10,859
Seaspine Orthopedics Corporation35$9,578
Globus Medical5$278
Cerapedics Inc.2$133
Johnson & Johnson1$60

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$194,479 in reported general payments places this provider in the 75th percentile of 57 orthopaedic surgery of the spine providers in Georgia.

See all orthopaedic surgery of the spine providers in Georgia

Medicare billing

Part B allowed, 2024
$400,956
Medicare patients
290
Services billed
1,411

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin96$1,786
Oxycodone Hcl206$1,629
Gabapentin145$1,537
Tizanidine Hcl156$898
Ondansetron Hcl154$603
Tramadol Hcl84$483
Methylprednisolone62$342
Acetaminophen-CodeineAcetaminophen With Codeine27$329
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen36$304
Methocarbamol48$304
Diclofenac Sodium24$232
Baclofen22$180
Cyclobenzaprine Hcl25$89
Meloxicam22$79
Diazepam13$8

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →